BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Geribaldi-Doldán N, Hervás-Corpión I, Gómez-Oliva R, Domínguez-García S, Ruiz FA, Iglesias-Lozano I, Carrascal L, Pardillo-Díaz R, Gil-Salú JL, Nunez-Abades P, Valor LM, Castro C. Targeting Protein Kinase C in Glioblastoma Treatment. Biomedicines 2021;9:381. [PMID: 33916593 DOI: 10.3390/biomedicines9040381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Qie Y, Cheng Z, Wu Z, Qi F, Li B, Wu S, Chu T, Lu Z, Li S, Nie G. Identification of protein kinase C beta as a therapeutic target for neuroendocrine prostate cancer and development of a nanoparticle-based therapeutic strategy. Nano Today 2023;48:101705. [DOI: 10.1016/j.nantod.2022.101705] [Reference Citation Analysis]
2 Meng Y, Sun J, Zhang G, Yu T, Piao H. The prognostic significance of genes involved in glycolysis, immunity, and epithelial-to-mesenchymal transition in glioblastoma.. [DOI: 10.21203/rs.3.rs-2462020/v1] [Reference Citation Analysis]
3 Hirtz A, Bailly Y, Rech F, Pierson J, Dumond H, Dubois-Pot-Schneider H. Molecular Characterization of the Dual Effect of the GPER Agonist G-1 in Glioblastoma. Int J Mol Sci 2022;23. [PMID: 36430793 DOI: 10.3390/ijms232214309] [Reference Citation Analysis]
4 Huang Q, Chen L, Liang J, Huang Q, Sun H. Neurotransmitters: Potential Targets in Glioblastoma. Cancers 2022;14:3970. [DOI: 10.3390/cancers14163970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Thakur A, Faujdar C, Sharma R, Sharma S, Malik B, Nepali K, Liou JP. Glioblastoma: Current Status, Emerging Targets, and Recent Advances. J Med Chem 2022. [PMID: 35786935 DOI: 10.1021/acs.jmedchem.1c01946] [Reference Citation Analysis]
6 Rodriguez SMB, Staicu GA, Sevastre AS, Baloi C, Ciubotaru V, Dricu A, Tataranu LG. Glioblastoma Stem Cells-Useful Tools in the Battle against Cancer. Int J Mol Sci 2022;23:4602. [PMID: 35562993 DOI: 10.3390/ijms23094602] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Bi Y, Wu ZH, Cao F. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma. BMC Cancer 2022;22:233. [PMID: 35241019 DOI: 10.1186/s12885-022-09328-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Lambrou GI. Epigenetics and personalized medicine of brain cancer. Epigenetics in Precision Medicine 2022. [DOI: 10.1016/b978-0-12-823008-4.00017-2] [Reference Citation Analysis]
9 Yueh PF, Lee YH, Fu CY, Tung CB, Hsu FT, Lan KL. Magnolol Induces the Extrinsic/Intrinsic Apoptosis Pathways and Inhibits STAT3 Signaling-Mediated Invasion of Glioblastoma Cells. Life (Basel) 2021;11:1399. [PMID: 34947930 DOI: 10.3390/life11121399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Zhu J, Su J. Alterations of the Gut Microbiome in Recurrent Malignant Gliomas Patients Received Bevacizumab and Temozolomide Combination Treatment and Temozolomide Monotherapy. Indian J Microbiol 2022;62:23-31. [DOI: 10.1007/s12088-021-00962-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]